Incyte Corp
NASDAQ:INCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Incyte Corp
NASDAQ:INCY
|
US |
|
S
|
Supercom Ltd
F:50S
|
IL |
|
G
|
G8 Education Ltd
SWB:3EAG
|
AU |
|
E
|
Evergreen Max Cash Capital Bhd
KLSE:EMCC
|
MY |
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
NL |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
DUS:ME9
|
IT |
|
G
|
Grupo Ecoener SA
MAD:ENER
|
ES |
|
Earth Corp
TSE:4985
|
JP |
|
E
|
Exxaro Resources Ltd
JSE:EXX
|
ZA |
|
EnviroMetal Technologies Inc
F:7N20
|
CA |
|
Elnusa Tbk PT
IDX:ELSA
|
ID |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
|
P
|
Papyrus Australia Ltd
ASX:PPY
|
AU |
|
China Merchants Port Holdings Co Ltd
OTC:CMHHY
|
HK |
|
Tryg A/S
OTC:TGVSF
|
DK |
|
Leshan Electric Power Co Ltd
SSE:600644
|
CN |
|
Bandai Namco Holdings Inc
OTC:NCBDF
|
JP |
|
T
|
Taisei Corp
XMUN:TKK1
|
JP |
Bankruptcy Probability
Incyte Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Incyte Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Incyte Corp
NASDAQ:INCY
|
23.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
61B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Incyte Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Incyte Corp has total debt of 28.4m USD. This includes both short-term (0 USD) and long-term (28.4m USD) debt.
You can find a full breakdown on its Balance Sheet.